Organon to conduct multinational studies in patients with breast cancer

In the large, multinational (25 countries), multicenter (150 hospitals) clinical trials, Organon intends to assess the effect and safety of Livial (tibolone) in patients with the history of breast cancer who have complained their climacteric symptoms and to enhance their quality of life. In Korea, Seoul National University Hospital, Seoul Asan Hospital, and Hanyang University Hospital are sched...